View of Investigation of Terminalia arjuna as potential IL-4 and IL-13 modulator for the prevention of autoimmune diabetes: A Pharmacoinformatics-based study

Return to Article Details Investigation of Terminalia arjuna as potential IL-4 and IL-13 modulator for the prevention of autoimmune diabetes: A Pharmacoinformatics-based study Download Download PDF